Enrolled patients, n | 30 |
Male sex, n (%) | 7 (23.3) |
Age, Median (range) | 69.0 (54–82) |
Performance status, n (%) | |
 0 | 22 (73.3) |
 1 | 6 (20.0) |
 2 | 2 (6.6) |
 3 | 0 |
 4 | 0 |
Smoking history (pack-years) | |
 0 | 16 |
 1–19 | 5 |
 ≥ 20 | 9 |
Histology, n (%) | |
 adenocarcinoma | 28 (93.3) |
 adenosquamous | 2 (6.6) |
Stage, n (%) | |
 IIIB | 2 (6.6) |
 IV | 21 (70.0) |
 postoperative recurrence | 7 (23.3) |
Type of mutations, n (%) | |
 19del | 25 (83.3) |
 L858R | 5 (16.6) |
Metastasis, n (%) | |
 brain | 7 (23.3) |
 liver | 4 (13.3) |
 adrenal | 7 (23.3) |
 bone | 16 (53.3) |
 malignant pleural effusion | 10 (33.3) |
 extrathoracic | 20 (66.6) |